NEW YORK (GenomeWeb News) – UK-based point of care diagnostics firm EKF Diagnostics Holdings today announced it has formed a new firm to focus on molecular and companion diagnostics.

To support the creation of the new subsidiary called EKF Molecular Diagnostics, EKF also said that it has acquired cancer diagnostics company 360 Genomics for up to £9.6 million ($14.5 million).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.